U.S. Orthopedic Contract Manufacturing Market (2025 - 2033)

U.S. Orthopedic Contract Manufacturing Market Summary

The U.S. orthopedic contract manufacturing market size was estimated at USD 2.48 billion in 2024 and is projected to reach USD 7.28 billion by 2033, growing at a CAGR of 13.16% from 2025 to 2033. The market growth is driven by increased procedural volumes related to joint reconstruction, trauma, and spine surgeries.

Besides, growth is further supported by rising original equipment manufacturers (OEMs) outsourcing operations to enhance efficiency and shorten time-to-market. In addition, the rising aging population and a growing sports injuries have contributed to the increased demand for orthopedic implants and surgical instruments. Moreover, the cost pressures have led OEMs to depend on contract manufacturers for precision machining, cleanroom assembly, and regulatory support, fueling the long-term collaborations throughout the supply chain. Besides, technological innovations have notably impacted implant design, instrumentation, and sterilization methods. 3D printing has gained momentum, particularly for creating patient-specific implants and tools. High-performance materials like PEEK, titanium alloys, and bioresorbables are increasingly being utilized.

The integration of digital manufacturing tools, automation, and AI-driven quality control systems into production processes has increased. There has also been exploration into innovative surgical instruments and IoT-enabled trays for better hospital inventory management and procedural planning. Substantial capital investments have enhanced advanced manufacturing capabilities and vertically integrated service offerings. U.S.-based contract development and manufacturing organizations (CDMOs) have received funding to expand their CNC machining, injection molding, additive manufacturing, and cleanroom packaging abilities. Private equity firms and OEMs have also engaged in strategic acquisitions and joint ventures to consolidate their strengths and achieve a competitive advantage in rapidly growing areas such as extremities and spine operations. These investments align with the increasing demand for speed, scalability, and regulatory adherence. The regulatory landscape in the U.S. is complex yet well-defined, with contract manufacturers required to adhere to the FDA’s Part 820 (Quality System Regulation) and ISO standards. There has been heightened scrutiny regarding design traceability, sterilization validation, and supply chain risk management.

Moreover, implementing Unique Device Identification (UDI) requirements and post-market surveillance has necessitated continuous documentation and digital compliance. Manufacturers are expected to maintain audit readiness and transparency across distributed production networks. Despite these advancements, the market faces several challenges. Rising raw materials and labor costs have created pricing pressures for contract manufacturers. Supply chain disruptions, particularly concerning specialty alloys and resins, have delayed production. Regulatory uncertainties affecting new implant materials and additive manufacturing technologies have also hindered the speed of bringing products to market. Besides, consolidation among OEMs has intensified pricing competition and reduced the number of high-volume clients, presenting challenges for smaller and mid-sized contract manufacturers. Such factors are expected to drive the growth of the U.S. orthopedic contact manufacturing industry.

Opportunity Analysis

The U.S. orthopedic contract manufacturing market is experiencing new opportunities due to an increasing demand for value-added services such as design-for-manufacturing (DFM), rapid prototyping, and comprehensive regulatory support. As OEMs prioritize their core competencies, there is likely to be a rise in the outsourcing of complex implants, innovative instruments, and tailored surgical kits. The growth of ambulatory surgical centers (ASCs) and outpatient procedures has led to a heightened need for disposable and pre-configured trays and cases, providing manufacturers with opportunities for innovation. Furthermore, integrating additive manufacturing and robotics offers chances to stand out through enhanced precision and faster production times. Specialized segments like extremities, pediatrics, and bioresorbable implants remain relatively untapped and present potential for custom manufacturing solutions. Additionally, reshoring efforts and the demand for FDA-compliant, traceable supply chains incentivize OEMs to collaborate with U.S.-based CDMOs. These trends create strategic opportunities for nimble manufacturers emphasizing scalability, technological integration, and regulatory compliance.

Technological advancements are transforming the orthopedic contract manufacturing market in the U.S. Besides, the key innovations include additive manufacturing (3D printing) for custom implants, particularly in spine and extremity applications, using materials like titanium and PEEK. Innovative surgical instruments are being developed with sensors and electronics for real-time feedback. Enhanced CNC machining and robotics are improving efficiency and precision in producing components such as bone screws and plates. Surface modification methods, like plasma spray and HA coating, are being implemented to boost implant integration and durability. Finally, integrated digital manufacturing platforms streamline compliance and improve market responsiveness through real-time connectivity and traceability.

In the orthopedic contract manufacturing sector in the U.S., pricing strategies differ based on the complexity of projects, risk-sharing arrangements, and the value provided. Milestone-based pricing connects payments to crucial development or production phases, such as reaching a design freeze, creating prototypes, and submitting for regulatory approval. This approach aligns costs with progress and encourages timely execution. Fixed-fee pricing models are often employed for high-volume, standardized products like bone screws and plates, offering OEMs a budget while necessitating a well-defined scope to prevent budget overruns. Value-based pricing is becoming more significant, particularly for innovative implants and smart instruments that improve clinical results or decrease surgery time, as it ties pricing to tangible healthcare value, promoting a performance-driven mindset. Additionally, subscription or retainer models are preferred in long-term partnerships, allowing OEMs to pay ongoing fees for consistent access to services such as design assistance or regulatory consultancy. These factors are expected to ensure that capacity is available and support agile product development in fast-changing, multi-product orthopedic lines.

Market Concentration & Characteristics

The U.S. orthopedic contract manufacturing market growth stage is moderate, and growth is accelerating. The market is characterized by the degree of innovation, level of M&A activities, regulatory impact, service expansion, and regional expansion.

The need for customized implants, intelligent surgical instruments, and innovative materials such as PEEK and bioresorbable fuels innovation in the U.S. orthopedic contract manufacturing industry. Technologies like additive manufacturing, automation, and digital integration transform product design, enhance production speed, and improve value-added services throughout the orthopedic sector.

M&A activity in the U.S. orthopedic contract manufacturing market is significant as contract manufacturers aim to gain complementary strengths in additive manufacturing, regulatory support, and cleanroom assembly. The pace of consolidation backed by private equity is speeding up, especially among mid-market Contract Development and Manufacturing Organizations (CDMOs), to improve vertical integration and cater to a diversified range of orthopedic portfolios.

Regulations are crucial in shaping operations, mandating compliance with FDA QSR and ISO 13485 throughout all manufacturing stages. The changing guidelines regarding UDI, MDR harmonization, and the validation of additive manufacturing add to the complexity, making it essential to implement digital traceability and robust quality management systems for access to the market.

Service offerings are broadening to encompass design for manufacturability (DFM), rapid prototyping, sterilization, and regulatory consulting. Contract manufacturers are transforming into comprehensive partners, providing OEMs with complete solutions from initial concept to commercialization, particularly in personalized implants and surgical system integration.

Orthopedic CMOs in the U.S. are increasing their presence in nearshore locations such as Mexico and Costa Rica to enhance cost efficiency and supply chain flexibility. Meanwhile, the Midwest and Southeast regions are experiencing facility growth, fueled by their proximity to OEM clusters and the availability of skilled manufacturing labor.

Type Insights

The implants segment dominated the U.S. orthopedic contract manufacturing market in 2024. The segment’s growth is driven by an increase in surgical procedures, an aging population, and a greater tendency among OEMs to outsource for better scalability and cost-effectiveness. These implants are widely used in spine, joint reconstruction, and extremities, further supporting the segment growth. Innovations like 3D printing, advanced biomaterials, and surface modifications are improving product performance and customization options. In addition, contract manufacturers are increasingly providing design, prototyping, and regulatory assistance to address the intricate, high-precision requirements for implants amid a competitive and quality-focused environment. Such factors are expected to drive the market over the estimated period.

On the other hand, the instruments segment is expected to witness considerable growth over the forecast period. The growth is driven by the need for precision-engineered surgical tools, both reusable and single-use. As original equipment manufacturers (OEMs) aim to optimize costs and accelerate product development cycles, there is a growing trend to outsource instrument production to specialized contract manufacturers that offer capabilities such as CNC machining, laser cutting, and cleanroom assembly. The industry is also evolving by introducing innovative, sensor-enabled instruments and ergonomic designs focused on minimally invasive procedures. Adhering to FDA and ISO standards and providing rapid prototyping and design-for-manufacturing services are crucial differentiators in this quality- and efficiency-centered sector. Such factors are expected to drive the market over the estimated time period.

Service Insights

The forging/casting segment dominated the U.S. orthopedic contract manufacturing industry with the largest share in 2024. The forging/casting in the U.S. is essential for creating high-strength, load-bearing components used in implants and surgical tools. The demand stems from the requirement for durable and anatomically precise parts in joint reconstruction and trauma treatments. OEMs are increasingly turning to contract manufacturers specializing in precision forging, investment casting, and post-processing treatments. Moreover, these commonly employed materials include titanium alloys and cobalt-chromium. Also, to achieve both scalability in production and adherence to regulatory standards, manufacturers prioritize automation, tighter tolerances, and quality certifications to ensure consistent performance.

On the other hand, the spine & trauma segment is anticipated to showcase the fastest CAGR during the forecast period. The rising incidence of spinal disorders and traumatic injuries drives the segment’s growth. Original Equipment Manufacturers (OEMs) increasingly turn to specialized Contract Development and Manufacturing Organizations (CDMOs) for complex manufacturing tasks such as precision machining, assembly, and sterilization to improve efficiency and ensure compliance. Besides, rising demand is further strengthened by advancements in implant materials, minimally invasive surgical methods, and tailored solutions. Stringent regulatory requirements and quality standards mean manufacturers are investing in innovative technologies like additive manufacturing and digital traceability. This factor presents rising new opportunities due to growing procedure volumes and changing clinical demands.

Key U.S. Orthopedic Contract Manufacturing Company Insights

The key industry players operating in the orthopedic contract manufacturing industry are actively undertaking key strategic initiatives such as service launches, mergers & acquisitions, partnerships & collaborations, and expansions to capture significant market share in the country. For instance, in July 2025, Straits Orthopaedics announced the acquisition of Medin Technologies, Inc. (“Medin”), which operates two facilities located in Totowa, New Jersey, and Manchester, New Hampshire. This strategic initiative marks a significant milestone in Straits’ growth strategy, strengthening its dedication to expanding its product portfolio and enhancing its global manufacturing footprint.

Recent Developments

• In April 2025,MedTech, Tyber Medical, Intech, & Resolve Surgical Technologies announced a merger to form a unified, leading organization dedicated to the design, development, and manufacturing of surgical devices for MedTech OEMs and patients. This newly formed group integrates advanced implant and instrumentation platforms with deep development and regulatory capabilities, delivering accelerated, high-performance solutions. The merger sets a new benchmark in innovation, speed-to-market, and strategic collaboration across the global orthopedic and surgical device industry.

• In November 2024, Viant Medical Inc. announced the acquisition of Knightsbridge Plastics, expanding its service portfolio to include micro-molding capabilities for medical device OEMs. This strategic move underscores Viant’s continued commitment to investing in advanced technologies that enable its customers to bring innovative medical solutions to the market more efficiently.

U.S. Orthopedic Contract Manufacturing Market